Details of the Drug Formulation (DFM)
| General Information of DFM (ID: F23210) | |||||
|---|---|---|---|---|---|
| Name | Lifitegrast 50 mg/ml solution | ||||
| Company | Novartis Pharmaceuticals Corporation | ||||
| Active Pharmaceutical Ingredient (API) | Lifitegrast | API Info  click to show the detail info of this API | |||
| Approved | |||||
| Drug Inactive Ingredient (DIGs) | |||||
| DIG ID | DIG Info | DIG Name | DIG Functional Class | ||
| E06YUO | DIG Info | Disodium hydrogenorthophosphate | Buffering agent ... | ||
| E0H0KW | DIG Info | Hydrochloric acid | Acidulant | ||
| E0T4TW | DIG Info | Sodium chloride | Diluent ... | ||
| E0L2PN | DIG Info | Sodium hydroxide | Alkalizing agent | ||
| E0H4PD | DIG Info | Sodium thiosulfate | Antioxidant | ||
| E0H2SC | DIG Info | Water | Solvent | ||
| Full List of Biological Targets of DIG (DBTs) Regulated by DIG(s) in This DFM | ||||||
|---|---|---|---|---|---|---|
| Lyase/isomerase/ligase (L/I/G) | ||||||
| DBT Name: Carbonic anhydrase IV (CA4) | Click to Show/Hide | |||||
| Detailed Information | DBT Info  click to show the detail info of this DBT | |||||
| Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Interacting DIG | Hydrochloric acid | |||||
| Biological Activity | Ki = 90000 nM (tested by experiment) | [1] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CAH4_HUMAN | |||||
| DBT Name: Carbonic anhydrase V (CA5) | Click to Show/Hide | |||||
| Detailed Information | DBT Info  click to show the detail info of this DBT | |||||
| Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Interacting DIG | Hydrochloric acid | |||||
| Biological Activity | Ki = 156 nM (tested by experiment) | [2] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CAH5A_HUMAN ; CAH5B_HUMAN | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.
